RESULTS
Patients
Of the 1,371 patients recruited for the
study, 1,348 Dutch type 2 diabetes
patients completed questionnaires regarding
quality of life and treatment satisfaction.
In total, 1,224 questionnaires
(91%) contained a completed Euroqol
VAS score, and 1,136 (84%) contained
complete information on the EQ5D. The
average age in this population was 64.9
years, and half of the patients were
women (50.2%). Approximately twothirds
of the patients used oral glucose–
lowering drugs; treatment of the
remaining patients was evenly divided between
diet/exercise and insulin therapy.
Almost half of the patients had no complications,
22% only microvascular complications,
15% only macrovascular
complications, and 16% had both types of
complications.